DAY ONE BIOPHARMACEUTICALS I's ticker is DAWN and the CUSIP is 23954D109. A total of 59 filers reported holding DAY ONE BIOPHARMACEUTICALS I in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $90,050 | -6.6% | 7,339 | -9.1% | 0.06% | -3.5% |
| Q2 2023 | $96,392 | +53.9% | 8,073 | +72.3% | 0.06% | +67.6% |
| Q1 2023 | $62,638 | -55.1% | 4,685 | -27.7% | 0.03% | -53.4% |
| Q4 2022 | $139,493 | +5.7% | 6,482 | -1.8% | 0.07% | +37.7% |
| Q3 2022 | $132,000 | +12.8% | 6,601 | +0.8% | 0.05% | +23.3% |
| Q2 2022 | $117,000 | +33.0% | 6,551 | -26.3% | 0.04% | +10.3% |
| Q1 2022 | $88,000 | -44.7% | 8,886 | -5.6% | 0.04% | -35.0% |
| Q4 2021 | $159,000 | – | 9,413 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners XI LLC | 9,663,645 | $95,863,000 | 39.92% |
| Atlas Venture Life Science Advisors, LLC | 8,201,638 | $81,360,000 | 10.29% |
| RA Capital Management | 6,060,090 | $60,116,000 | 1.31% |
| Boxer Capital, LLC | 1,189,943 | $11,804,000 | 0.61% |
| Samsara BioCapital, LLC | 202,500 | $2,009,000 | 0.51% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,086,449 | $20,698,000 | 0.46% |
| BVF INC/IL | 809,282 | $8,028,000 | 0.32% |
| Summit Rock Advisors, LP | 33,125 | $329,000 | 0.20% |
| Perceptive Advisors | 556,047 | $5,516,000 | 0.11% |
| Nan Fung Group Holdings Ltd | 11,445 | $114,000 | 0.05% |